Diphtheria toxin fused to variant interleukin-3 provides enhanced binding to the interleukin-3 receptor and more potent leukemia cell cytotoxicity

This publication has 28 references indexed in Scilit:

• Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention
  Leukemia, 2003
• The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex
  The Journal of cell biology, 2003
• Interleukin‐3 Promotes Proliferation and Differentiation of Human Hematopoietic Stem Cells but Reduces Their Repopulation Potential in NOD/SCID Mice
  The International Journal of Cell Cloning, 2003
• Cancer Statistics, 2003
  CA: A Cancer Journal for Clinicians, 2003
• Diphtheria toxin-interleukin-3 fusion protein (DT388IL3) prolongs disease-free survival of leukemic immunocompromised mice
  Leukemia, 2003
• Elevated expression of IL-3Rα in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis
  Blood, 2002
• Receptor Binding Kinetics of Human IL-3 Variants with Altered Proliferative Activity
  Biochemical and Biophysical Research Communications, 2001
• An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells
  Cell Death & Differentiation, 2001
• Molecular Characterization of Key Diphtheria Toxin:Receptor Interactions
  Biochemical and Biophysical Research Communications, 2000
• The crystal structure of diphtheria toxin
  Nature, 1992